Enzymlogic's CSO to present at the Protein Kinases in Drug Discovery Conference
May , 9th 2014
Enzymlogic has been selected by the Advisory Board of the Protein Kinases In Drug Discovery Conference to give an Oral Presentation on May 9 in Berlin, Germany. The conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on drug discovery aspects within the protein kinases field.
Enzymlogic's CSO will be presenting our latest results on applying high throughput kinetics for the discovery of novel inhibitors. Our findings show the importance of the early evaluation and optimization of binding kinetics for controlling in vivo drug behavior, improving decision-making and driving chemical diversity.